CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,014 | +32.7% | 31,205 | +2.9% | 0.07% | +16.4% |
Q1 2024 | $764 | -42.9% | 30,315 | -26.4% | 0.06% | -46.0% |
Q4 2023 | $1,339 | -19.5% | 41,210 | -32.5% | 0.11% | -21.0% |
Q3 2023 | $1,664 | -20.0% | 61,089 | -34.6% | 0.14% | -31.2% |
Q2 2023 | $2,079 | +3.5% | 93,460 | +0.8% | 0.21% | +4.5% |
Q1 2023 | $2,008 | -20.4% | 92,689 | -25.4% | 0.20% | -36.4% |
Q4 2022 | $2,523 | -99.6% | 124,226 | +374.0% | 0.31% | +251.7% |
Q3 2022 | $672,000 | +92.0% | 26,206 | +78.2% | 0.09% | +67.9% |
Q2 2022 | $350,000 | +31.6% | 14,704 | +24.5% | 0.05% | +47.2% |
Q1 2022 | $266,000 | -36.1% | 11,813 | -44.2% | 0.04% | -14.3% |
Q3 2021 | $416,000 | +9.8% | 21,154 | -32.5% | 0.04% | -4.5% |
Q4 2019 | $379,000 | +11.8% | 31,317 | +30.5% | 0.04% | -4.3% |
Q3 2019 | $339,000 | -34.3% | 23,989 | -45.4% | 0.05% | -11.5% |
Q1 2019 | $516,000 | -32.5% | 43,953 | -23.1% | 0.05% | -40.9% |
Q4 2018 | $764,000 | +135.1% | 57,151 | +146.3% | 0.09% | +388.9% |
Q3 2018 | $325,000 | -81.1% | 23,200 | -78.8% | 0.02% | -78.8% |
Q2 2018 | $1,719,000 | -45.6% | 109,382 | -43.1% | 0.08% | -49.1% |
Q1 2018 | $3,161,000 | +102.1% | 192,182 | +122.0% | 0.17% | +75.8% |
Q4 2017 | $1,564,000 | -46.4% | 86,582 | -42.8% | 0.10% | -52.3% |
Q3 2017 | $2,920,000 | +158.2% | 151,282 | +57.8% | 0.20% | +168.9% |
Q2 2017 | $1,131,000 | -70.1% | 95,882 | -72.2% | 0.07% | -63.5% |
Q1 2017 | $3,786,000 | +36.2% | 345,476 | -9.7% | 0.20% | +22.3% |
Q4 2016 | $2,779,000 | +11.1% | 382,776 | -0.6% | 0.17% | +23.9% |
Q3 2016 | $2,502,000 | +10.7% | 384,976 | -7.0% | 0.13% | +7.2% |
Q2 2016 | $2,260,000 | +99.1% | 413,902 | +70.6% | 0.12% | +73.6% |
Q1 2016 | $1,135,000 | +102.0% | 242,604 | +114.9% | 0.07% | +157.1% |
Q4 2015 | $562,000 | +185.3% | 112,892 | +115.1% | 0.03% | +180.0% |
Q3 2015 | $197,000 | -73.5% | 52,491 | -57.5% | 0.01% | -64.3% |
Q2 2015 | $742,000 | – | 123,491 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
S&T BANK/PA | 347,260 | $7,727 | 1.39% |
FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |